{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:01:57Z","timestamp":1782205317829,"version":"3.54.5"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.expneurol.2008.01.026","type":"journal-article","created":{"date-parts":[[2008,2,19]],"date-time":"2008-02-19T14:43:37Z","timestamp":1203432217000},"page":"252-258","source":"Crossref","is-referenced-by-count":21,"title":["AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons"],"prefix":"10.1016","volume":"211","author":[{"given":"J.D.","family":"Elsworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"D.E.","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leranth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.B.","family":"Bjugstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"J.R.","family":"Sladek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Samulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.P.","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2008.01.026_bib1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresbull.2005.04.009","article-title":"Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor","volume":"66","author":"Ahn","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2008.01.026_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib3","series-title":"Functional Neural Transplantation","article-title":"Functional studies of neural grafts in parkinsonian primates","author":"Annett","year":"1994"},{"key":"10.1016\/j.expneurol.2008.01.026_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/exnr.1993.1185","article-title":"Trophism, transplantation, and animal models of Parkinson's disease","volume":"124","author":"Bankiewicz","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib5","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuroscience.2007.03.057","article-title":"Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro","volume":"147","author":"Borgal","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.01.026_bib6","series-title":"Functional Neural Transplantation","first-page":"9","article-title":"Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rat striatum","author":"Brundin","year":"1994"},{"key":"10.1016\/j.expneurol.2008.01.026_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/096368970000900205","article-title":"Improving the survival of grafted dopaminergic neurons: a review over current approaches","volume":"9","author":"Brundin","year":"2000","journal-title":"Cell Transplant"},{"key":"10.1016\/j.expneurol.2008.01.026_bib8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.nbd.2005.09.008","article-title":"Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia","volume":"21","author":"Carlsson","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2008.01.026_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0165-3806(94)00197-8","article-title":"Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat","volume":"85","author":"Choi-Lundberg","year":"1995","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.expneurol.2008.01.026_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1460-9568.1990.tb00419.x","article-title":"Effect of prior dopamine denervation on survival and fiber outgrowth from intrastriatal fetal mesencephalic grafts","volume":"2","author":"Doucet","year":"1990","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0306-4522(95)00564-1","article-title":"Early gestational mesencephalon grafts, but not later gestational mesencephalon, cerebellum or sham grafts, increase dopamine in caudate nucleus of MPTP-treated monkeys","volume":"72","author":"Elsworth","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.01.026_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0306-4522(99)00437-6","article-title":"Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment","volume":"95","author":"Elsworth","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.01.026_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1515\/REVNEURO.2005.16.4.303","article-title":"Assessment of GDNF in primate models of Parkinson's disease: comparison with human studies","volume":"16","author":"Eslamboli","year":"2005","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/096368970000900107","article-title":"Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor","volume":"9","author":"Espejo","year":"2000","journal-title":"Cell Transplant"},{"key":"10.1016\/j.expneurol.2008.01.026_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6123(08)60321-0","article-title":"Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2-3,6-tetrahydropyridine","volume":"78","author":"Fine","year":"1988","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2008.01.026_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46\u00a0months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib18","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1111\/j.1460-9568.2004.03770.x","article-title":"Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor","volume":"20","author":"Georgievska","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib19","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1523\/JNEUROSCI.1122-04.2004","article-title":"Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system","volume":"24","author":"Georgievska","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib20","first-page":"119","article-title":"Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications","volume":"99","author":"Grieger","year":"2005","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib21","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.expneurol.2008.01.026_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.brainresbull.2004.10.013","article-title":"Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective","volume":"68","author":"Hagell","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2008.01.026_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn863","article-title":"Dyskinesias following neural transplantation in Parkinson's disease","volume":"5","author":"Hagell","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archneur.56.2.179","article-title":"Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease","volume":"56","author":"Hauser","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1471-4159.2002.00881.x","article-title":"Species differences in the expression of multiple tyrosine hydroxylase protein isoforms","volume":"81","author":"Haycock","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2008.01.026_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nn1175","article-title":"Localized striatal delivery of GDNF as a treatment for Parkinson disease","volume":"7","author":"Kirik","year":"2004","journal-title":"Nat. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2008.01.026_bib27","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1002\/ana.10485","article-title":"In vivo gene delivery of glial cell line\u2013derived neurotrophic factor for Parkinson's disease","volume":"53","author":"Kordower","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(97)01495-9","article-title":"Topographical distribution of [125I]-glial cell line-derived neurotrophic factor in unlesioned and MPTP-lesioned rhesus monkey brain following a bolus intraventricular injection","volume":"789","author":"Lapchak","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2008.01.026_bib29","doi-asserted-by":"crossref","first-page":"17644","DOI":"10.1074\/jbc.M512194200","article-title":"Differential regulation of the human tyrosine hydroxylase isoforms via hierarchical phosphorylation","volume":"281","author":"Lehmann","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2008.01.026_bib30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1126\/science.8493557","article-title":"GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons","volume":"260","author":"Lin","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2008.01.026_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1515\/CCLM.2001.056","article-title":"Cell therapy and transplantation in Parkinson's disease","volume":"39","author":"Lindvall","year":"2001","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0079-6123(02)38091-9","article-title":"Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF","volume":"138","author":"McBride","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.expneurol.2008.01.026_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0166-2236(96)80038-5","article-title":"Fetal nigral transplantation as a therapy for Parkinson's disease","volume":"19","author":"Olanow","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib35","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1128\/JVI.78.13.6808-6817.2004","article-title":"Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats","volume":"78","author":"Paterna","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/107385802237703","article-title":"Cellular replacement therapy for Parkinson's disease\u2014where we are today?","volume":"8","author":"Redmond","year":"2002","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2008.01.026_bib37","first-page":"419","article-title":"Restoring normal nigrostriatal anatomy in dopamine-depleted monkeys","volume":"175","author":"Redmond","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib38","first-page":"979","article-title":"Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts","volume":"75","author":"Rosenblad","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.01.026_bib39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/glycob\/6.5.489","article-title":"Brain extracellular matrix","volume":"6","author":"Ruoslahti","year":"1996","journal-title":"Glycobiology"},{"key":"10.1016\/j.expneurol.2008.01.026_bib40","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/exnr.1997.6718","article-title":"Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts","volume":"149","author":"Sautter","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/exnr.1993.1207","article-title":"Regional and cell-specific expression of GDNF in rat brain","volume":"124","author":"Schaar","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.20861","article-title":"Crossroads in GDNF therapy for Parkinson's disease","volume":"21","author":"Sherer","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2008.01.026_bib43","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1097\/00001756-199611040-00029","article-title":"GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts","volume":"7","author":"Sinclair","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2008.01.026_bib44","series-title":"Techniques for Neural Transplantation","first-page":"391","article-title":"Techniques for neural transplantation in non-human primates","author":"Sladek","year":"1995"},{"key":"10.1016\/j.expneurol.2008.01.026_bib45","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.gt.3302549","article-title":"AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL","volume":"12","author":"Sondhi","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2008.01.026_bib46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","article-title":"Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease","volume":"327","author":"Spencer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib47","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/mds.10588","article-title":"Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats","volume":"18","author":"Steece-Collier","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2008.01.026_bib48","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1006\/exnr.1993.1214","article-title":"Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo","volume":"124","author":"Stromberg","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2008.01.026_bib49","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1046\/j.1460-9568.1998.00378.x","article-title":"Growth\/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease","volume":"10","author":"Sullivan","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00229411","article-title":"Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls","volume":"85","author":"Taylor","year":"1991","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2008.01.026_bib51","series-title":"Toxin-Induced Models of Neurological Disorders","first-page":"139","article-title":"Behavioral effects of MPTP administration in the vervet monkey: a primate model of Parkinson's disease","author":"Taylor","year":"1994"},{"key":"10.1016\/j.expneurol.2008.01.026_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0306-4522(97)00214-5","article-title":"Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)","volume":"81","author":"Taylor","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2008.01.026_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum. Gene Ther."},{"issue":"Suppl 1","key":"10.1016\/j.expneurol.2008.01.026_bib54","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1002\/jgm.506","article-title":"Recombinant AAV-mediated gene delivery to the central nervous system","volume":"6","author":"Tenenbaum","year":"2004","journal-title":"J. Gene Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib55","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1096\/fasebj.7.11.8370483","article-title":"Extracellular matrix. 2: role of extracellular matrix molecules and their receptors in the nervous system","volume":"7","author":"Venstrom","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2008.01.026_bib56","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"327","author":"Widner","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.expneurol.2008.01.026_bib57","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1523\/JNEUROSCI.19-06-02301.1999","article-title":"A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra","volume":"19","author":"Wilby","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2008.01.026_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/exnr.1998.6884","article-title":"Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue","volume":"153","author":"Yurek","year":"1998","journal-title":"Exp. Neurol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608000599?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488608000599?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T00:19:33Z","timestamp":1557274773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488608000599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0014488608000599"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2008.01.026","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}